Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus

Zika virus (ZIKV), a mosquito-borne flavivirus, was an almost neglected pathogen until its introduction in the Americas in 2015, where it has been responsible for a threat to global health, causing a great social and sanitary alarm due to its increased virulence, rapid spread, and an association wit...

Full description

Bibliographic Details
Main Authors:	Juan-Carlos Saiz, Nereida Jiménez de Oya, Ana-Belén Blázquez, Estela Escribano-Romero, Miguel A. Martín-Acebes
Format:	Article
Language:	English
Published:	MDPI AG 2018-08-01
Series:	Viruses
Subjects:	flavivirus Zika virus therapy host-directed antivirals
Online Access:	http://www.mdpi.com/1999-4915/10/9/453

Similar Items

Lipid Metabolism as a Source of Druggable Targets for Antiviral Discovery against Zika and Other Flaviviruses
by: Miguel A. Martín-Acebes, et al.
Published: (2019-06-01)

Zika virus: the latest newcomer
by: Juan-Carlos eSaiz, et al.
Published: (2016-04-01)

Zika virus infection confers protection against West Nile virus challenge in mice<subtitle>Zika virus protects against West Nile virus</subtitle>
by: Ángela Vázquez-Calvo, et al.
Published: (2017-01-01)

Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models
by: Nereida Jiménez de Oya, et al.
Published: (2019-01-01)

4,7-Disubstituted 7<i>H</i>-Pyrrolo[2,3-d]pyrimidines and Their Analogs as Antiviral Agents against Zika Virus
by: Ruben Soto-Acosta, et al.
Published: (2021-06-01)

Effects of Statin Combinations on Zika Virus Infection in Vero Cells
by: Erica Españo, et al.
Published: (2022-12-01)

Zika Virus Inhibitors Based on a 1,3-Disubstituted 1<i>H</i>-Pyrazolo[3,4-<i>d</i>]pyrimidine-amine Scaffold
by: Eunkyung Jung, et al.
Published: (2022-09-01)

In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate)
by: Paweł Botwina, et al.
Published: (2020-08-01)

Antiviral Activity of Benzavir-2 against Emerging Flaviviruses
by: Yong-Dae Gwon, et al.
Published: (2020-03-01)

Protective to a T: The Role of T Cells during Zika Virus Infection
by: Ryan D. Pardy, et al.
Published: (2019-08-01)

Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp
by: Zhuang Wang, et al.
Published: (2022-06-01)

Evasion of Innate and Intrinsic Antiviral Pathways by the Zika Virus
by: Taryn M. Serman, et al.
Published: (2019-10-01)

Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro, Una, and Zika Viruses
by: Dalkiria Campos, et al.
Published: (2020-04-01)

Current trends in Zika vaccine development
by: Francisco A. Lagunas-Rangel, et al.
Published: (2017-07-01)

Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference
by: Alexandre Sze, et al.
Published: (2017-10-01)

Zika in travellers 1947-2017 : a systematic review
by: Wilder-Smith, Annelies, et al.
Published: (2020)

Zika Virus NS2A-Mediated Virion Assembly
by: Xianwen Zhang, et al.
Published: (2019-10-01)

In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
by: Zhong Li, et al.
Published: (2022-04-01)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation
by: Hadrián Álvarez-Fernández, et al.
Published: (2022-11-01)

Current Progress of Avian Vaccines Against West Nile Virus
by: Nereida Jiménez de Oya, et al.
Published: (2019-09-01)

Zika Virus from the Perspective of Observational Studies: a Review
by: Tayyab Saleem, et al.
Published: (2023-02-01)

Zika Virus Replicons for Drug Discovery
by: Xuping Xie, et al.
Published: (2016-10-01)

Astrocyte Control of Zika Infection Is Independent of Interferon Type I and Type III Expression
by: Mithun Das, et al.
Published: (2022-01-01)

Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo
by: Zhong Li, et al.
Published: (2020-01-01)

The Anti-Dengue Virus Peptide DV2 Inhibits Zika Virus Both In Vitro and In Vivo
by: Maria Fernanda de Castro-Amarante, et al.
Published: (2023-03-01)

Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
by: Michela Mazzon, et al.
Published: (2019-02-01)

Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses
by: Renato AS Oliveira, et al.

A vaccine effective against Zika virus is theoretically possible but may not be delivered anytime soon
by: Taylor-Robinson AW
Published: (2016-07-01)

Chikungunya and Zika Viruses: Co-Circulation and the Interplay between Viral Proteins and Host Factors
by: Sineewanlaya Wichit, et al.
Published: (2021-04-01)

Zika virus infection: The resurgence of a neglected disease
by: Tushar Kambale, et al.
Published: (2016-01-01)

Zika virus: an alert for prevention
by: Deysi Licourt Otero, et al.
Published: (2018-05-01)

Zika vaccines and therapeutics: landscape analysis and challenges ahead
by: Annelies Wilder-Smith, et al.
Published: (2018-06-01)

Zika Virus Seroprevalence, French Polynesia, 2014–2015
by: Maite Aubry, et al.
Published: (2017-04-01)

An Update on Sexual Transmission of Zika Virus
by: Hercules Sakkas, et al.
Published: (2018-08-01)

MicroRNA and mRNA Dysregulation in Astrocytes Infected with Zika Virus
by: Robert A. Kozak, et al.
Published: (2017-10-01)

Zika virus as an emerging arbovirus of international public health concern
by: Samira Vaziri, et al.
Published: (2022-10-01)

Cell-active carbazole derivatives as inhibitors of the zika virus protease
by: Rassias, Gerasimos, et al.
Published: (2021)

Antiviral Agents in Development for Zika Virus Infections
by: Mariana Baz, et al.
Published: (2019-06-01)

Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus
by: Ángela Vázquez-Calvo, et al.
Published: (2017-07-01)

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine
by: Yujiao Yang, et al.
Published: (2017-03-01)